Huabang Health: Announcement of Resolutions of the 14th Meeting of the Eighth Board of Supervisors
Huabang Health: Feasibility analysis report on the development of forward foreign exchange settlement services and RMB to foreign exchange option portfolios in 2025
Huabang Health: Supervisory Board Rules of Procedure (December 2024)
Huabang Health: Shareholders\' Meeting Rules of Procedure (December 2024)
Huabang Health: Announcement on the Company and its subsidiaries applying for credit lines and guarantee matters from banks and other financial institutions in 2025
Huabang Health: Articles of Association (December 2024)
Huabang Health: Administrative Measures on the Use of Funds Raised (December 2024)
Huabang Health: Independent opinions of independent directors on matters related to the 21st meeting of the 8th board of directors
Huabang Health: Announcement of Resolutions of the 21st Meeting of the Eighth Board of Directors
Huabang Health: Announcement on increasing the forecast for daily related transactions in 2024 and the expected daily related transactions for 2025
Huabang Health: 002004 Huabang Health Investor Relations Management Information 20241129
Huabang Health: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in Chongqing
Huabang Health: Announcement of Board Resolutions
Huabang Health: Public Opinion Management System (October 2024)
Huabang Health: Voluntary Information Disclosure Notice on Keji Dalong Obtaining an Agricultural Genetically Modified Biosafety Certificate
Huapont Life Sciences: 002004 Huabang Health Investor Relations Management Information 20240429
Huapont Life Sciences: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Huapont Life Sciences: Report on the work of the Board of Supervisors for the year 2023
Huapont Life Sciences: Announcement of Board Resolutions
Huapont Life Sciences: Announcement on the renewal of the 2024 Audit Institution